Derun Zheng
Shanghai, 200240, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Mutant p53 reactivation and DNA demethylation in the treatment of AML/MDS.
Journal: Science translational medicine
Published: August 12, 2026
p53 mutation-associated prognosis across cancer types underlines hematological malignancy as an applicable cancer type to p53-rescue therapy.
Journal: Fundamental research
Published: December 23, 2024
RIG-I-Inducing Small Molecules Potently Inhibit HMA-Resistant AML Through Igniting the Overloaded dsRNA Arsenal.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 07, 2024
Characterization of the generic mutant p53-rescue compounds in a broad range of assays.
Journal: Cancer cell
Published: July 24, 2023
Arsenic trioxide extends survival of Li-Fraumeni syndrome mimicking mouse.
Journal: Cell death & disease
Published: July 07, 2023
Pharmacological rescue of mutant p53 triggers spontaneous tumor regression via immune responses.
Journal: Cell reports. Medicine
Published: June 12, 2023
Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties.
Journal: Science translational medicine
Published: April 05, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026